Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma
This study is currently recruiting participants.
Verified January 2013 by Bristol-Myers Squibb
Sponsor:
Bristol-Myers Squibb
Collaborator:
AbbVie
Information provided by (Responsible Party):
Bristol-Myers Squibb
ClinicalTrials.gov Identifier:
NCT01441973
First received: September 27, 2011
Last updated: February 22, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | May 2014 |
| Estimated Primary Completion Date: | February 2013 (Final data collection date for primary outcome measure) |